Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 08/29/2024 at 14:05, 2 months 23 days ago

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination

COVID-19 Moderna Vaccination Health Campaign Public Awareness
PRESS RELEASE

published on 08/29/2024 at 14:00, 2 months 23 days ago

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination
Moderna launches 'Do It For You & Them' campaign to drive vaccination rates in the U.S. and inform about COVID-19 risks & impact, updated vaccines available for KP.2 variant

COVID-19 Moderna Awareness Campaign KP.2 Variant Vaccination Rates
BRIEF

published on 08/23/2024 at 13:05, 2 months 29 days ago

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

Public Health European Commission MRNA Technology RSV Vaccine Moderna Approval
PRESS RELEASE

published on 08/23/2024 at 13:00, 2 months 29 days ago

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
Moderna receives European Commission approval for mRESVIA(R) (mRNA-1345) vaccine to fight RSV in adults aged 60+; significant breakthrough beyond COVID-19

European Commission Moderna Vaccine RSV MRESVIA
BRIEF

published on 08/23/2024 at 07:30, 2 months 29 days ago

Japan Approves Updated Moderna COVID-19 Vaccine Targeting SARS-CoV-2 Variant JN.1

COVID-19 Vaccine Moderna Japan Approval SARS-CoV-2 Variant JN.1
PRESS RELEASE

published on 08/23/2024 at 07:25, 2 months 29 days ago

Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Moderna receives approval in Japan for updated Spikevax vaccine targeting SARS-CoV-2 variant JN.1, aligning with WHO recommendations, to be part of Japan's national immunization program

COVID-19 Vaccine Japan Moderna SARS-CoV-2 Spikevax
BRIEF

published on 08/22/2024 at 13:05, 2 months 30 days ago

Moderna to Host Investor Event - R&D Day and Business Updates

Webcast Moderna Investor Event R&D Day Business Updates
PRESS RELEASE

published on 08/22/2024 at 13:00, 2 months 30 days ago

Moderna to Host Investor Event - R&D Day and Business Updates
Moderna, Inc. to host Investor Event - R&D Day and Business Updates on September 12, 2024, discussing development strategies and key considerations. Webcast available on website

Webcast MRNA Medicine Moderna Investor Event Development Strategies
BRIEF

published on 08/22/2024 at 06:05, 2 months 30 days ago

Moderna Receives FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant

COVID-19 FDA Approval Moderna Vaccine KP.2 Variant
PRESS RELEASE

published on 08/22/2024 at 06:00, 2 months 30 days ago

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Moderna's Spikevax 2024-2025 formula FDA-approved for individuals 12 and above to target KP.2 variant and prevent COVID-19. Availability in U.S. pharmacies imminent

COVID-19 FDA-approved Moderna Spikevax 2024-2025 Formula

Accesswire

Published on 11/22/2024 at 00:00, 5 hours 57 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 52 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 7 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 42 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 47 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 10 hours 56 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 21 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 59 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 12 hours 6 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours 6 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 22 hours 59 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 12 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 22 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE